Rxo (RXO) Share-based Compensation (2021 - 2026)

Rxo (RXO) has 6 years of Share-based Compensation data on file, last reported at $7.0 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation changed 0.0% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $29.0 million (up 16.0% YoY), and the FY2025 full-year result was $29.0 million, up 26.09% from the prior year.
• Share-based Compensation for Q1 2026 stood at $7.0 million, roughly flat from $7.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $23.0 million in Q4 2022 and bottomed at $2.0 million in Q1 2022.
• The 5-year median for Share-based Compensation is $6.0 million (2023), against an average of $6.5 million.
• The widest annual swing landed in 2022, when Share-based Compensation surged 1050.0%; it then plunged 86.96% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $23.0 million in 2022, then slumped by 86.96% to $3.0 million in 2023, then soared by 100.0% to $6.0 million in 2024, then gained by 16.67% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• The last three Share-based Compensation figures came in at $7.0 million (Q1 2026), $7.0 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.

Peer Comparison